| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $27.6M | -43.3% | +72.6% |
| R&D Expense | $35.6M | +3.3% | -2.1% |
| SG&A Expense | $14.1M | -5.4% | +2.1% |
| Operating Income | -$22.1M | -3180.4% | +35.4% |
| Pre-tax Income | -$18.3M | -957.2% | +38.3% |
| Income Tax | $1.3M | +818.3% | +491.2% |
| Net Income | -$19.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $64.8M | -34.0% | -47.0% |
| Accounts Receivable | $29.4M | +1015.6% | +23.8% |
| Current Assets | $291.7M | -1.5% | -15.1% |
| Total Assets | $397.3M | -2.7% | -18.5% |
| Current Liabilities | $42.0M | +9.2% | -49.9% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$22.7M | — | — |
| Capital Expenditures | $940K | — | — |
| Investing Cash Flow | $21.3M | — | — |
| Financing Cash Flow | $183K | — | — |
| Free Cash Flow | -$23.7M | — | — |
| -946.0% |
| +34.3% |
| EPS (Basic) | -$0.26 | -966.7% | +33.3% |
| EPS (Diluted) | -$0.26 | -966.7% | +33.3% |
| $77.2M |
| +4.5% |
| -35.8% |
| Stockholders' Equity | $320.1M | -4.3% | -12.8% |